Key Takeaways:
- The project will collect biological data from a much wider range of cell types.
- Google, Meta, and other partners are providing $300 million in new funding, computing resources, and data tools for Google Meta AI drug research.
- The initiative aims to help researchers better understand how cells respond to treatments and speed up drug research.
Google, Meta, and the United States government joined Biohub on Wednesday to launch a $1.8 billion initiative to build open datasets and develop artificial intelligence tools for medical research.
Tech Giants And Government Fund Biohub Biology Project
Google DeepMind, Meta, and the United States government have joined Biohub to support a large scientific research effort in Google Meta AI drug research. The organizations committed $300 million in new funding, computing resources, and data tools for the project.
The new support brings the initiative’s total commitments from public and private partners to $1.8 billion. Biohub described the collaboration as the largest coordinated effort so far to create biological data that can be used to develop AI tools.
The project brings technology companies and public research groups together to collect large amounts of biological data. Biohub is a nonprofit research institute backed by leaders including Mark Zuckerberg and Priscilla Chan.
Researchers plan to measure how living cells respond to different changes across a much wider range of cell types than has been studied before. The goal is to give scientists better data for studying how cells work and how they respond to treatments.
Isomorphic Labs President Highlights The Scale Of The Project
Industry leaders said solving difficult biological problems requires resources that are beyond what a single company can provide today. Isomorphic Labs President Max Jaderberg shared his views on the project in a public statement.
Jaderberg said researchers need to collect data on a much larger scale to build computer systems that can predict how biological systems behave. The project aims to address that need by bringing companies and research organizations together.
Studying human cells on a large scale requires significant computing power and large amounts of consistent data. By working together, the participating organizations can combine their technology, research capabilities, and funding.
Commercial funders will have access to the data for one year before Biohub makes the generated data available to the wider scientific research community.
Open Data Could Help Speed Up Drug Discovery
The Virtual Biology Initiative plans to create open datasets that researchers around the world can use. These datasets will help train computer systems to predict how cells may respond to different treatments and changes in their environment.
By using computer models to study how cells respond, researchers hope to shorten the time needed to develop new drugs. Better prediction tools could also help pharmaceutical companies identify promising drug candidates earlier in the development process.
The initiative also focuses on creating consistent and organized biological data that researchers can share and use. Researchers hope that computer models capable of predicting how biological systems work could be available within five years of development.
The National Institutes of Health and the Department of Energy are also taking part in the Google Meta AI drug research project to help coordinate U.S. government support for the research effort.
Visit Visionary CIOs to read more.
